d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP [2781]
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP
| SMILES | CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 |
| InChIKey | DRLYXDZRLDZVIS-XXNQTUAPSA-N |
| Sequence | CYFVNCPR |
Chemical Properties
| Hydrogen bond acceptors | 13 |
| Hydrogen bond donors | 10 |
| Rotatable bonds | 17 |
| Log P | 0.329 |
| Molecular weight (Da) | 1078.5 |
| Stereochemistry info | unspecified |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0